Equities analysts expect Edap Tms SA (NASDAQ:EDAP) to announce $6.19 million in sales for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Edap Tms’ earnings, with the highest sales estimate coming in at $6.33 million and the lowest estimate coming in at $6.04 million. Edap Tms posted sales of $14.04 million during the same quarter last year, which suggests a negative year over year growth rate of 55.9%. The business is expected to announce its next quarterly earnings report on Wednesday, August 26th.
On average, analysts expect that Edap Tms will report full year sales of $30.51 million for the current financial year, with estimates ranging from $27.61 million to $33.40 million. For the next fiscal year, analysts expect that the business will post sales of $43.88 million, with estimates ranging from $39.39 million to $48.36 million. Zacks Investment Research’s sales averages are a mean average based on a survey of analysts that that provide coverage for Edap Tms.
Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings results on Wednesday, May 13th. The medical equipment provider reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.02). The company had revenue of $8.30 million for the quarter, compared to analyst estimates of $9.02 million. Edap Tms had a return on equity of 20.15% and a net margin of 4.38%.
Shares of EDAP traded down $0.04 during mid-day trading on Monday, reaching $2.52. The company had a trading volume of 69,122 shares, compared to its average volume of 71,978. Edap Tms has a 52-week low of $1.46 and a 52-week high of $5.39. The company has a quick ratio of 1.94, a current ratio of 2.41 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $74.22 million, a P/E ratio of 35.93 and a beta of 1.64. The stock has a 50 day moving average of $2.51 and a two-hundred day moving average of $3.20.
Several hedge funds have recently made changes to their positions in the company. Cahill Financial Advisors Inc. acquired a new stake in Edap Tms in the 1st quarter valued at $307,000. Morgan Stanley lifted its holdings in Edap Tms by 26.2% during the first quarter. Morgan Stanley now owns 549,943 shares of the medical equipment provider’s stock valued at $1,249,000 after purchasing an additional 114,195 shares in the last quarter. Wellington Management Group LLP acquired a new stake in shares of Edap Tms in the first quarter valued at about $615,000. Personal CFO Solutions LLC grew its position in shares of Edap Tms by 203.3% in the first quarter. Personal CFO Solutions LLC now owns 45,500 shares of the medical equipment provider’s stock valued at $103,000 after purchasing an additional 30,500 shares during the period. Finally, Sunbelt Securities Inc. purchased a new stake in shares of Edap Tms during the fourth quarter worth about $5,360,000. 18.16% of the stock is owned by institutional investors and hedge funds.
About Edap Tms
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).
Recommended Story: Monthly Dividend Stocks Can Provide Solid Income
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.